competitor for unilife's drug pumps, page-2

there are a few companies out there developing similar pumps. you can google them.

but we are told that none can match the unilife ones and we have the experts in the pump business.

if we can get those signed contracts sooner rather than later, this will be further validated.


- - -

In November 2012, Unilife announced that its platform of bolus injection devices had been selected by a global pharmaceutical company to enter a final stage of evaluation as its preferred choice for use in a multi-drug program. Unilife's bolus injectors have also been selected by many other pharmaceutical companies for targeted use with late-stage pipeline drugs. Negotiations for agreements are underway in each case.

- - -

Mr. Alan Shortall, CEO of Unilife, said, "Our Precision-Therapy™ platform of bolus injectors and Flex-Therapy™ platform of infusion pumps are consistently being identified by pharmaceutical companies as the preferred technology for the long-duration subcutaneous delivery of injectable drugs.